Capital Farma DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Kewpie Releases Choline EX, New Food with Function Claims

22 Oct 2024

// PRESS RELEASE

Ono inks $700M biobuck deal to bag preclinical LigaChem ADC

11 Oct 2024

// FIERCE BIOTECH

Gritstone files for bankruptcy in hope of keeping R&D afloat

11 Oct 2024

// BIOSPACE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

IPEX Indonesia

Not Confirmed

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

1 CORPORATE CONTENT #SupplierSpotlight

media
1 CORPORATE CONTENT #SupplierSpotlight

ACTIVE PHARMA INGREDIENTS

2 All APIs, 2 Listed APIs

2 All APIs
2 Listed APIs

KEY PRODUCTS

Galantamine Hydrobromide, Silver Sulfadiazine

Galantamine Hydrobromide
Silver Sulfadiazine

Capital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

About

Capital Farma offers a comprehensive range of pharmaceutical solutions. Our API offering includes active ingredients sourced exclusively from top European manufacturers, ensuring the highest quality and innovation. Additionally, we co-develop proprietary APIs with leading European Contract Manufacturing Organizations (CMOs), offering complete product packages by combining them with Finished Dosage Form (FDF) dossiers. Through our licensing services, we also offer FDF licenses to help clients expand their market reach and boost sales in regions with limited access. Partner with us for reliable, high-quality pharmaceutical products.